SOX9 and lung carcinoma: Correlating to the transforming capacity, absence of p38 activity induces an upregulation of the expression of the stem and lung cancer marker Sox9 [9], [10] in K-RasG12 cells (Fig. 2D and Fig. S1F) supporting its potential as a therapeutic target.